University of Pittsburgh

Similar documents
University of Pittsburgh

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media Randomization Phase

RESEARCH CONSENT FORM

Pablo Tebas, M.D. Joseph Quinn, RN, BSN Yan Jiang, RN, BSN, MSN

Dr. Kristin Heins, ND Thrive Natural Family Health 110 Eglinton Avenue East, Suite 502 Toronto, Ontario M4P 2Y1 Telephone: (647)

First Aid, CPR and AED

Participant Information Sheet Adults

Advance Medical Directives

UK LIVING WILL REGISTRY

Scripps Clinic Medical Group (SCMG) and SCRIPPS HEALTH INFORMED CONSENT STATEMENT FOR. Study Title: SCMG & Scripps Health Bio-Repository

TheValues History: A Worksheet for Advance Directives Courtesy of Somerset Hospital s Ethics Committee


Facing Serious Illness: Make Your Wishes Known to your Health Care Professional

Advance Directive. What Are Advance Medical Directives? Deciding What You Want. Recording Your Wishes

INFORMED CONSENT TO PARTICIPATE IN A DIABETES RESEARCH REGISTRY

ACCOUNT NO. MED. REC. NO. NAME BIRTHDATE. Patient Identification ALL ORDERS MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE.


INFORMATION ABOUT HEALTH CARE DECISONS. Health Care Proxy MOLST DNR

DELAWARE Advance Directive Planning for Important Healthcare Decisions

2

Psychological Services Agreement

Generator or box changes for your implantable device

ADVANCE DIRECTIVE FOR HEALTH CARE

INSTRUCTIONS FOR YOUR CALIFORNIA ADVANCE HEALTH CARE DIRECTIVE

My Voice - My Choice

Are you participating in any other research studies? Yes No

NOTICE OF PRIVACY PRACTICES

NOTICE OF PRIVACY PRACTICES

PATIENT INFORMATION FLEXIBLE SIGMOIDOSCOPY YOUR QUESTIONS ANSWERED

INFORMED CONSENT DOCUMENT. Project Title: The Contraceptive Choice Center: an innovative health services delivery and payment model

CALIFORNIA Advance Directive Planning for Important Health Care Decisions

Goals & Objectives 4/17/2014 UNDERSTANDING ADVANCE HEALTH CARE DIRECTIVES (AHCD) By Maureen Kroning, EdD, RN. Why would someone need to do this?

PATIENT INFORMATION RESPONSIBLE PARTY INFORMATION NAME: DOB: SEX: M / F SOCIAL SECURITY # RELATIONSHIP TO PATIENT: PHONE #: CELL#: EMPLOYER:

PATIENT NOTICE OF PRIVACY PRACTICES Effective Date: June 1, 2012 Updated: May 9, 2017

Advance Health Care Directive (California Probate Code section 4701)

CALIFORNIA Advance Directive Planning for Important Health care Decisions

COLORADO Advance Directive Planning for Important Healthcare Decisions

Advance Health Care Directive. LIFE CARE planning. my values, my choices, my care. kp.org/lifecareplan

ADVANCE HEALTH CARE DIRECTIVE Including Power of Attorney for Health Care (California Probate Code Sections effective JULY 1, 2000)

STATUTORY FORM ADVANCE HEALTH CARE DIRECTIVE (California Probate Code Section 4701)

CALIFORNIA ADVANCE HEALTH CARE DIRECTIVE

MASSACHUSETTS Advance Directive Planning for Important Healthcare Decisions

Patient Self-Determination Act

THE CHILDREN S INSTITUTE OF PITTSBURGH NOTICE OF PRIVACY PRACTICES

NOTICE OF PRIVACY PRACTICES

NEW HAMPSHIRE Advance Directive Planning for Important Health Care Decisions

Basic Guidelines for Using the Advance Health Care Directive Form

This notice describes Florida Hospital DeLand s practices and that of: All departments and units of Florida Hospital DeLand.

Critical Care What Makes this so Difficult

HIPAA Notice of Privacy Practices DFD Russell Medical Center Effective April 14, 2003 Updated April 10, 2013

Advance Directive for Health Care

LOUISIANA ADVANCE DIRECTIVES

FAMILY PHARMACEUTICAL SERVICES NOTICE OF PRIVACY PRACTICES effective 9/23/2013

NEBRASKA Advance Directive Planning for Important Healthcare Decisions

LIFE CARE planning. Advance Health Care Directive. my values, my choices, my care WASHINGTON. kp.org/lifecareplan

Karen LeVasseur, LCSW Calm4Kids Therapy Center, LLC 514 Main Street Bradley Beach, NJ

OREGON Advance Directive Planning for Important Healthcare Decisions

RECEIPT OF NOTICE OF PRIVACY PRACTICES WRITTEN ACKNOWLEDGEMENT FORM. I,, have received a copy of Dr. Andy Hand s Notice of Privacy Practice.

WEST VIRGINIA Advance Directive Planning for Important Health Care Decisions

483.10(b)(4) and (8) Rights Regarding Advance Directives, Treatment, and Experimental Research

WYOMING Advance Directive Planning for Important Healthcare Decisions

Patient rights and responsibilities

PERSONAL HEALTH INFORMATION PROTECTION ACT (PHIPA) Frequently Asked Questions (FAQ s) Office of Access and Privacy

Advance Directive. including Power of Attorney for Health Care

VIRGINIA Advance Directive Planning for Important Health Care Decisions

GEORGIA Advance Directive Planning for Important Health Care Decisions

Advance Health Care Directive Form Instructions

A PATIENT S GUIDE TO UNDERSTANDING ADVANCE HEALTH CARE DIRECTIVES. By Maureen Kroning EdD, RN

DOWNLOAD COVERSHEET:

YOUR RIGHT TO DECIDE YOUR RIGHT TO DECIDE YOUR RIGHT TO DECIDE

VIRGINIA Advance Directive Planning for Important Health Care Decisions

Your Guide to Advance Directives

Annex VIIIA Guideline for correct preparation of a model patient information sheet and informed consent form (PIS/ICF)

Sandra V Heinsz, Ph.D. Informed Consent Services Agreement

ALASKA ADVANCE HEALTH CARE DIRECTIVE for Client

GEORGIA ADVANCE DIRECTIVE FOR HEALTH CARE

PEDIATRIC HEALTH ASSOCIATES HIPAA NOTICE OF PRIVACY PRACTICES

Vermont Advance Directive for Health Care

NO TALLAHASSEE, June 30, Mental Health/Substance Abuse

WELCOME. Payment will be expected at the time of service. Please remember our 24 hour cancellation notice.

ADVANCE DIRECTIVE INFORMATION

HARDY, MILSTEAD, VAUGHT & MADONNA, M.D., P.A. PRIVACY PRACTICES Effective: 1/1/03

MEDICAL POWER OF ATTORNEY DESIGNATION OF HEALTH CARE AGENT.

POLST Discussions Doing it Better. Clinical Update in Geriatric Medicine. Judith S. Black, MD, MHA. POLST Overview. Faculty Disclosure PART I

Health Care Proxy Appointing Your Health Care Agent in New York State

NOTICE OF PRIVACY PRACTICES

MY ADVANCE DIRECTIVE

NOTICE OF PRIVACY PRACTICES

A PERSONAL DECISION

DURABLE HEALTH CARE POWER OF ATTORNEY AND HEALTH CARE TREATMENT INSTRUCTIONS (LIVING WILL) PART I INTRODUCTORY REMARKS ON HEALTH CARE DECISION MAKING

1.2 ADULT CLIENT INTAKE FORM: Client Information

VIRGINIA ADVANCE DIRECTIVE FOR HEALTH CARE

ADVANCE HEALTH CARE DIRECTIVE. (California Probate Code Section 4701) Explanation

Advance Directives The Patient s Right To Decide CH Oct. 2013

MASSACHUSETTS ADVANCE DIRECTIVES

Advance Health Care Directives. Form Instructions

Orthopedic Specialty Clinic, Ltd. Updated 05/2014

What Does a Consent Form Look Like at Different Reading Levels?

INFORMED CONSENT FOR TREATMENT

Transcription:

University of Pittsburgh Departments of Critical Care and Emergency Medicine CONSENT TO ACT AS A SUBJECT IN A RESEARCH STUDY TITLE: CARDIAC ARREST BIOMARKER AND PHYSIOLOGY STUDY (CABAPS) Principal Investigator: Co-Investigators: Study Sponsor: Cameron Dezfulian, MD 3434 Hill Building Pittsburgh PA, 15260 Department of Critical Care Medicine Dezfulianc@upmc.edu Patrick Coppler (study coordinator) Jonathan Elmer, MD (secondary study coordinator) Clifton Callaway MD/PhD Ankur Doshi MD Frank Guyette MD Jon C Rittenberger MD/MS Lilian Emlet MD Sajid Kadir MD Hulya Bayir, MD Sruti Shiva PhD Matthew Murnin Peter Adams University of Pittsburgh School of Medicine Department of Critical Care Medicine Department of Emergency Medicine Purpose of the Study You or your loved one has suffered a cardiac arrest, a life threatening medical condition. Very little is known about the body s response to and the ways in which damage occur to the organs following a cardiac arrest. The Departments of Critical Care and Emergency Medicine are conducting a trial that is aimed at studying the body s response and ways in which injury occur after cardiac arrest. We plan to measure blood markers of circulation, metabolism, and the function of a subcellular organelle known as the mitochondria in the early hours and subsequent day after a cardiac arrest and correlate these markers with damage to the organs and the outcomes of cardiac arrest survivors. Study Procedures As part of this study, we are asking to use: 1) Information in your medical record Page 1 of 5

2) Blood collected in the intensive care unit 3) Use of monitors which will monitor oxygen and blood flow in the hand before, during and after we inflate a blood pressure cuff on the forearm to briefly stop blood flow to the hand. Study investigators may have already collected blood samples at ICU admission. Blood will be taken from an existing line when available at 0-3, 12-18, 36-48 hours post arrest and at the day of intensive care discharge. The amount of blood drawn at each study time point is roughly 2 teaspoons and the total of all study blood draws will not exceed 10 teaspoons. Blood samples will be used to analyze markers of organ dysfunction. We will do a vaso-occlusion test at each study time point. The vaso-occlusion test consists of a blood pressure cuff on the forearm which is inflated to pressures higher than your blood pressure stopping blood flow for 5 minutes. A tissue oximetry device that measures oxygen saturation in the palm will be fixed to the area below your thumb and and a laser speckle camera which measures blood flow of the palm with be positioned above the hand. We will measure the rate at which oxygen and blood flow decrease when the cuff is inflated and revoers after it is deflated. In total we will make measures over approximately 20 minutes and the whole procedure should take 30 minutes at each time point. If you are found eligible for this research study and agree to be in this study, we will look at and write down information from your medical records. We want to keep track of general information about you, like your gender and age. All samples and data obtained from you will be assigned a number. We will keep a record of the number we assigned to you, but we will not give that number to anyone else. We will not give reports about the research we do to you or your doctor. We will not put the results in your medical record. The research results will not change the care you receive. We will also look at and write down information about your ambulance ride (if applicable) and your stay at UPMC immediately following this incident. We want to know about: your vital signs (pulse, breathing rate, weight, height) diagnoses doctors have given about your condition results of clinical lab tests medications you were given resuscitation efforts, which could include CPR, intubation, and IV transfusions. discharge location and neurological status at discharge Risk, Stress or Discomfort Risk of Blood Collection. There is minor risk of discomfort associated with the blood draws. If performed by venipuncture, it may cause bruising, bleeding, fainting, and rarely infection. Collection of blood from indwelling catheters (IV) could include clotting or malfunction of the catheter. This is the same risk as with any routine IV catheter placement. There is a risk of anemia with blood draws. To ensure this risk is minimal we will exclude you if your blood count (hemoglobin) is less than 8 grams per deciliter. By UPMC policy, we withhold blood transfusions usually until the blood count is below 7.5 so this cut off represents an effort to avoid putting you at additional risk for a transfusion. Risk of Vaso-occlusion Test. There is a minor risk of discomfort associated with the blood pressure cuff inflation. This includes numbness, tingling, and mild pain. If this occurs and is not tolerable by you, we will stop and not resume any procedures without your consent. Page 2 of 5

Confidentiality. We make every effort to keep the information about you confidential. You have been assigned a code number. This code number is used on all of the data we collected, including the blood samples. A key linking you to the code number is kept locked in a secure location and will be available only to the investigators. All patient identifiers (medical record number) will be removed from data within a year of the completion of the study. Laboratory samples will be destroyed as soon as analysis is complete. Data from this study, without your identity, may be reported in scientific meetings, articles or other appropriate communications. You will not be notified about the results of this study. Although we will make every effort to keep your information confidential, no system for protecting your confidentiality can be completely secure. It is possible that unauthorized persons might discover that you are in this study, or might obtain information about you. You will not be at greater risk than you are by being a patient in this hospital as we will use similar safeguards. University of Pittsburgh sometimes reviews studies such as this one to make sure they are being done safely and legally. If a review of this study takes place, your records may be examined. The reviewers will protect your privacy. The study records will not be used to put you at legal risk of harm. In addition to the investigators listed on the front page of this consent form and their research staff, the following individuals may have access to identifiable information related to your participation in this research study: Authorized representatives of federal and local agencies providing oversight, including University of Pittsburgh Research Conduct and Compliance Office, who may review your identifiable research information (which may include your identifiable medical record information) for the purpose of monitoring the appropriate conduct of this research study. In unusual cases, the investigators may be required to release identifiable information (which may include your identifiable medical information) related to your participation in this research study in response to an order from a court of law. If the investigators learn that you or someone with whom you are involved is in serious danger or potential harm, they will need to inform, as required by Pennsylvania law, the appropriate agencies. Alternatives to taking part in this study Being in this study is voluntary. You do not have to be in this study if you don t want to be. You can stop at any time. Whether you choose to be in this study, or choose not to be in this study, will not affect your health care here at UPMC. Benefits of the study We hope that the results of this study will gain understanding of post-cardiac arrest physiology and lead us to novel therapeutic targets that will improve future patient care. Costs and Payments You or your loved one will not be paid for participating in this study. If you decide to not participate in this study, your doctor will continue to treat you or your loved one according to their usual standard of care treatment plan. You and your insurer or third party payer will not be billed for research-related services, such as services related solely to the research; study specific lab work will be paid for by the research grant. However, you, or your insurer, will be billed for all other usual care services, and/or services not connected with the study, just as you would if not in the study. No follow up is required for this study. No additional costs will be accrued due to participation in this study. Right to Withdraw If you decide to withdraw from this study, this decision will not affect either your current or future medical care at the University of Pittsburgh Medical Center. If you agree to participate and later change your mind, or if you later decide to withdraw, a written and dated notice of this decision needs to be sent to the investigator. All information and samples collected prior to your withdrawal will continue to be used. The investigators may Page 3 of 5

continue to use and disclose, for the purposes described above, identifiable information (which may include your identifiable medical information) related to your participation in this research study indefinitely. Please note that it is University policy that all research records must be maintained for at least 7 years following final reporting or publication of a project. You have the right to request that all information collected to date and/or the blood samples be destroyed. Voluntary Participation Your doctor may be involved as an investigator in this research study. As both your doctor and a research investigator, he is interested both in your medical care and the conduct of this research study. Before agreeing to participate in this research study, or at any time during your study participation, you may discuss your care with another doctor who is not associated with this research study. You are not under any obligation to participate in any research study offered by your doctor. Voluntary Consent The study has been described to me and all of my questions have been answered. Any additional questions or concerns about any aspect of this study will be answered by the researchers if questions, concerns or complaints arise. Questions I might have about my rights as a research participant will be answered by the Human Subject Protection Advocate at 1-866-212-2668. By signing this form, I agree to participate in this research study. A copy of this consent form will be given to me. Participant s Signature Printed Name of Participant Date/Time Surrogate Consent ******* is unable to provide direct consent for study participation because: Participant s Name (Print) Therefore, by signing this form, I give my consent for his/her participation in this research study. Representative s Name (Print) Representative s Signature Witness Signature if faxing or Electronic transfer Relationship to Participant Date/Time Date /Time Investigator s Certification Page 4 of 5

I certify that the nature and purpose, the potential benefits and possible risks associated with participation in this research study have been explained to the subject or their family member and any questions about this information have been answered. Investigator s Name (Print) Investigator s Signature Date/Time Consent for continued research participation: I understand that I am currently participating in a research study. Permission for my participation in this study was obtained initially through the exception from informed consent requirement or from my authorized representative (surrogate) because of my inability to provide consent when initial permission was requested. I have now recovered to the point where I feel that I can provide direct consent for continued participation in this research study. The study has been described to me and all of my questions have been answered. I understand that I have the right to request that all information collected to date and /or my blood samples be destroyed. Any additional questions or concerns about any aspect of this study will be answered by the researchers. Questions I might have about my rights as a research participant will be answered by the Human Subject Protection Advocate at 1-866-212-2668. By signing below, I agree to continue my participation in this research study. A copy of this consent form will be given to me. Participant s Signature Participant s Name (Print) Date/Time Investigator s Certification I certify that the nature and purpose, the potential benefits and possible risks associated with participation in this research study have been explained to the subject or their family member and any questions about this information have been answered. Investigator s Name (Print) Investigator s Signature Date/Time Page 5 of 5